Results 111 to 120 of about 52,768 (299)
Background: In severe drug eruptions, precise evaluation of disease severity at an early stage is needed to start appropriate treatment. It is not always easy to diagnose these conditions at their early stage.
Takayoshi Komatsu-Fujii +7 more
doaj +1 more source
Hydroxychloroquine-induced repetitive atypical pustular drug eruptions in the same patient separated by 12 years. [PDF]
Chen J +4 more
europepmc +1 more source
Smart Biomaterials and Dressings for the Treatment of Chronic Inflammatory Skin Diseases
ABSTRACT Chronic inflammatory skin diseases, encompassing immune‐inflammatory conditions and infection‐associated dermatoses, pose significant clinical challenges due to high prevalence, recurrence, and therapeutic resistance, affect over 30% of the global population.
Zehao Lan +5 more
wiley +1 more source
Molar incisor hypomineralisation: current knowledge and practice
Background Molar incisor hypomineralisation (MIH) is a common developmental dental condition that presents in childhood. Areas of poorly formed enamel affect one or more first permanent molars and can cause opacities on the anterior teeth. MIH presents a variety of challenges for the dental team as well as functional and social impacts for affected ...
Helen D. Rodd +4 more
wiley +1 more source
Fixed Drug Eruptions With Flavoured Liquid Formulations of Over-the-Counter Analgesics: A Case Report. [PDF]
Alzahrani AH.
europepmc +1 more source
Acute generalized exanthematous pustulosis due to an iodinated contrast radiodiagnostic agent. [PDF]
peer reviewedIodinated contrast agents are frequently involved in delayed polymorphic adverse skin reactions. Acute generalized exanthematous pustulosis following administration of iodinated contrast agents is a rare but severe form of such reactions ...
Henry, Frédérique +4 more
core
A Zosteriform Papular Cutaneous Eruption
JEADV Clinical Practice, EarlyView.
Silvia Borriello +8 more
wiley +1 more source
Unilateral mastication, a common oral habit, induces cognitive decline in rats by disrupting hippocampal cholesterol metabolism. It triggers astrocyte hyperplasia, enhances cholesterol synthesis, impairs transport/degradation, and reduces 24‐hydroxycholesterol (24‐OHC), ultimately damaging synaptic function.
Xiaoting Zhai +9 more
wiley +1 more source
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki +24 more
wiley +1 more source
Fixed Drug Eruption with Pigmentation Induced by Etoricoxib: A Case Report
Fixed drug eruption with pigmentation is characterized by the appearance of erythematous or bullous lesions following the ingestion of certain medications.
Dextre-Vilchez, Sergio Armando +1 more
doaj +1 more source

